Marshall Wace North America’s Organigram Holdings OGI Stock Holding History

Marshall Wace North America’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-64,625	Closed	-$895K	–	1666
2021 Q1	$895K	Buy	+64,625	New	+$747K	﹤0.01%	1074
2019 Q4	–	Sell	-183,519	Closed	-$2.53M	–	1502
2019 Q3	$2.53M	Buy	183,519 +111,894	+156%	+$2.35M	0.01%	497
2019 Q2	$1.85M	Buy	+71,625	New	+$1.99M	0.01%	588

Other funds holding OGI

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marshall Wace North America's OGI Position: Q2 2021 in Review

Marshall Wace North America sold out of Organigram Holdings (OGI) in Q2 2021, closing a stake of 64,625 shares — an estimated $895K sold.

Marshall Wace North America first reported a position in OGI in Q2 2019 and held it in 3 quarters. The position peaked at $2.53M in Q3 2019. 142 funds tracked by Wall St. Rank hold OGI as of Q2 2021.

Marshall Wace North America reported no remaining Organigram Holdings position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 64,625 Organigram Holdings shares in Q2 2021, an estimated $895K.
Marshall Wace North America first reported a position in Organigram Holdings in Q2 2019 and held it in 3 quarters.
Marshall Wace North America's Organigram Holdings position peaked at $2.53M in Q3 2019.
142 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.